Oragenics Enters Into Materials Transfer Agreement With Adjuvance Systems for COVID-19 Vaccine Adjuvant
TAMPA, Fla.–(Business WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) introduced coming into into a substance transfer agreement with…